Research location
Mysore
India
Advertisement
Research activity in Mysore
IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 39 trials and 41 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mysore
39 linked trials · page 1 of 1A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityNCT07794579 · 2026-08-26 · 1 site observation
RECRUITING
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingNCT07613307 · 2026-07-15 · 1 site observation
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803 · 2026-06-29 · 1 site observation
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinNCT07392190 · 2026-02-10 · 1 site observation
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesNCT07321886 · 2026-02-06 · 1 site observation
RECRUITING
Yoga Based Cardiac Rehabilitation in Heart Failure FailureNCT07817589 · 2023-04-24 · 1 site observation
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596 · 2020-12-02 · 1 site observation
RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT04923347 · 2023-06-06 · 1 site observation
COMPLETED
A Study of Granexin Gel in the Treatment of Diabetic Foot UlcerNCT02667327 · 2018-11-21 · 1 site observation
TERMINATED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD PatientsNCT03022097 · 2017-02-02 · 1 site observation
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 2 site observations
COMPLETED
A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot UlcerNCT02236793 · 2014-12-01 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and AdolescentsNCT01444430 · 2011-12-01 · 1 site observation
COMPLETED
Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)NCT01431274 · 2011-09-01 · 1 site observation
COMPLETED
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesNCT01400971 · 2011-07-01 · 1 site observation
COMPLETED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
Phase IIb-III Study of BL-1020 Small Molecule for SchizophreniaNCT01363349 · 2011-05-01 · 1 site observation
TERMINATED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 2 site observations
COMPLETED
A Rheumatoid Arthritis Study in ParticipantsNCT01202760 · 2011-01-01 · 1 site observation
COMPLETED
A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateNCT01198002 · 2010-12-01 · 1 site observation
TERMINATED
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With MetforminNCT01210001 · 2010-09-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderNCT01193153 · 2010-09-01 · 1 site observation
COMPLETED
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma IINCT01172821 · 2010-08-01 · 1 site observation
COMPLETED
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)NCT01147250 · 2010-06-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)NCT01157078 · 2010-06-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderNCT01153347 · 2010-06-01 · 1 site observation
COMPLETED
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsNCT01107886 · 2010-05-01 · 1 site observation
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent AsthmaNCT00946569 · 2009-08-01 · 1 site observation
COMPLETED
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease IINCT00796653 · 2009-01-01 · 1 site observation
COMPLETED
Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma PatientsNCT00814216 · 2008-12-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast CancerNCT00669565 · 2008-07-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's DiseaseNCT00559871 · 2007-10-01 · 1 site observation
COMPLETED
Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.NCT00530166 · 2007-07-01 · 1 site observation
TERMINATED
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)NCT00297115 · 2006-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.